Vinflunine

Chemical formula: C₄₅H₅₄F₂N₄O₈  Molecular mass: 816.944 g/mol 

Therapeutic indications

Vinflunine is indicated for:

Transitional cell carcinoma of the urothelial tract

Population group: only adults (18 - 65 years old)

Vinflunine is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum-containing regimen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Transitional cell carcinoma of the urothelial tract

Population group: only elderly (65 years old or older)

Vinflunine is indicated in monotherapy for the treatment of elderly patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum-containing regimen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Vinflunine is contraindicated in the following cases:

Lactation

Lactation

Hypersensitivity to vinca alkaloids

Vinca alkaloid allergy

Infections

Infectious disease

Thrombocytopenia

at least one of
Platelet count below reference range
Acquired thrombocytopenia

Neutropenia

Neutropenia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.